KLA Corporation (KLAC) Q2 FY2026 Post-Earnings Debrief

1. Executive Summary

2. What Actually Mattered

1. DRAM cost headwind (75-100 bps) is the new variable. KLA uses custom DRAM chips in its inspection and metrology systems. HBM-driven DRAM supply tightness caused procurement costs to spike. This was NOT on any analyst model entering the call. The CFO described the change as having happened "profoundly over the past two to three months," suggesting KLA itself was surprised by the speed. March quarter is guided as the GM trough for CY2026. If DRAM capacity additions in H2 normalize costs as management expects, this is a temporary headwind. If not, it represents a new structural margin cap.

2. The H2 acceleration thesis faces a math problem. Rasgon's challenge was incisive: if CY2026 grows mid-single digits overall, and H1 is roughly flat due to supply constraints, then H2 needs to be up ~10% from H1. But WFE is also expected to grow at roughly that rate. So where is the above-market share gain that process control intensity is supposed to deliver? Management's response — blending in service and non-semi revenue — was not quantitatively satisfying. The share gain may exist but it's not visible in the aggregate revenue guidance.

3. DRAM intensity inflection is structural and underappreciated. The jump from 78% to 85% DRAM (within memory) in one quarter is the most important structural datapoint in the report. Wallace's comment that DRAM requirements now resemble advanced logic is a TAM expansion statement — it means the addressable process control spend in DRAM is permanently higher. HBM's stringent yield requirements, multi-layer stacking, and advanced lithography adoption are all driving this.

4. Supply constraints create certainty, not opportunity. "Virtually sold out" means H1 revenue is locked. It also means KLA cannot outperform its own guide materially in H1 — the ceiling is the same as the floor. The constraint is physical (optical components), not demand-driven, so demand softening in one segment can theoretically be replaced by another. But the practical implication is that H1 numbers are essentially known quantities.

5. Advanced packaging growth moderation is real but context-dependent. The guide-down from ">20%" to "mid to high teens" reflects facility constraints at customers (they can't build packaging fabs fast enough), not demand weakness. Wallace explicitly stated: "Part of what's slowing down the growth this year is their ability to have their factories built." This suggests the growth is being deferred to CY2027, not lost. But the deceleration is still a negative revision.

6. China affiliate rule reversal added ~$300-350M to the outlook. Rasgon extracted confirmation that the reversal of the affiliate rule added approximately $300-350M of previously lost China revenue back into the CY2026 forecast. China is now expected to be "modestly positive" versus the prior "modestly down" expectation. This is a meaningful swing but does not change the structural China risk.

3. Results vs. Expectations

Results vs. Prior Guidance

4. Historical Quarterly Comparison

5. Guidance Bridge & Implications

Forward Consensus Build

6. Estimate Revision Implications

NTM Consensus EPS Trajectory Since Earnings

7. Transcript Intelligence

Prepared Remarks: Management Emphasis

CEO Wallace led with CY2025 as a record year ($12.7B revenue, 17% growth, 29% EPS growth) before pivoting to AI as "a core driver of KLA's performance." The framing was that KLA is both an AI beneficiary (its tools enable AI chip manufacturing) and an AI practitioner (its systems use AI analytics). Advanced packaging received significant airtime — $950M in CY2025 systems revenue, exceeding 70% YoY growth. Service business durability (16th consecutive year of growth, $786M quarterly) was emphasized as a structural asset.

CFO Higgins introduced three new elements that drove the post-earnings reaction: (1) the WFE market sizing framework — explicitly breaking out core WFE ($110B → low $120B in CY2026) from advanced packaging ($11B → ~$12B) to yield "mid $130B" total, addressing the Lam Research definition discrepancy; (2) binding supply constraints ("virtually sold out," optical components as bottleneck); and (3) the DRAM cost headwind (75-100 bps GM impact, "changed profoundly over the past two to three months").

Q&A: Pressure Points

WFE Definition (Vivek Arya, BofA): First question — directly confronted the gap between KLA's "high single to low double" WFE forecast and Lam's 23% claim. Higgins explained the core vs. packaging disaggregation. Wallace added that customer facility constraints are limiting packaging growth. This was the most contested topic but is largely an apples-to-oranges issue once both definitions are aligned.

H2 Share Gain Math (Stacy Rasgon, Bernstein): The sharpest exchange. Rasgon calculated that mid-single-digit full-year growth with the H1/H2 cadence implies ~10% H2/H1 growth — roughly in-line with WFE, not above it. "Where is the share gain?" Higgins deflected to blended revenue composition (service, non-semi) but did not provide a quantitatively satisfying answer. This is a legitimate tension in the guidance framework that remains unresolved.

Supply Constraint Quantification (Quatrochi, Arya): Multiple analysts tried to size the revenue "left on the table." Higgins declined to quantify: "We don't really look at what we could have done." Wallace reframed supply constraints as industry-wide. The refusal to quantify suggests either the amount is modest or management doesn't want to create expectations for a H2 catch-up.

China Affiliate Rule (Rasgon): Rasgon pressed on the ~$300-350M revenue add from the affiliate rule reversal. Higgins confirmed the ballpark and that China revenue guidance moved from "modestly down" to "up" for CY2026.

Advanced Packaging Deceleration (Tim Arcuri, UBS): Arcuri caught the guide-down from ">20%" to "mid to high teens." Higgins downplayed it as small-market percentage variability, but this is a genuine narrative shift. Wallace attributed it to customer facility constraints pushing growth into CY2027.

Management Quotes by Theme

AI & Demand:

"AI remains a core driver of KLA's performance and a key factor in our growing industry leadership. As KLA solutions enable our customers to deliver products needed for AI, our systems are also applying AI-driven analytics to deliver actual insights that streamline chip manufacturing." — CEO, prepared remarks

Supply Constraints:

"We're virtually sold out across most of our products. Given the lead time of our products, our decisions that were driving in the first half are decisions made in 2025 generally." — CFO, Q&A

"When we talk to all our customers we hear a common theme — they're constrained by the ability to build new fabs and new shelves." — CEO, Q&A

DRAM Intensity:

"There's less redundancy, the value of these devices is higher... there's more metalization layers which require more inspection. And then the increased use of advanced lithography, which requires more EUV inspection." — CEO, on DRAM process control requirements

DRAM Cost Headwind:

"This pricing environment has changed profoundly over the past two to three months... current modeling suggests this situation will persist through 2026 and have roughly 75 to 100 basis points negative impact on gross margins for the calendar year." — CFO, prepared remarks

"We expect this pricing environment to be transitory. As DRAM capacity additions accelerate over the next several quarters, we expect this cost dynamic to improve as we exit the calendar year." — CFO, prepared remarks

Advanced Packaging:

"KLA's process control share... if you go back to 2021, we were roughly 10% of that market... now close to half the market share." — CFO, Q&A

"Part of what's slowing down the growth this year is their ability to have their factories built to support packaging because of the growth. So that's why we see a lot more growth in '27 as a result." — CEO, Q&A

CY2027 Setup:

"Our customers have told us '26 is expansion and setting the stage for even more expansion in '27." — CEO, Q&A

"Most of our conversations today about new orders are for deliveries late in '26 and into '27. So it's pretty clear from a visibility point of view we feel pretty good about our ability to ramp the business." — CFO, Q&A

8. Segment & KPI Forensic Review

Revenue Mix

The most significant KPI change was DRAM's share within memory revenue jumping from 78% to 85% — a 700 bps shift in one quarter. This reflects the rapid acceleration of HBM demand and the associated inspection/metrology requirements. DRAM process control intensity is approaching logic-like levels, which is a structural TAM expansion for KLA. The foundry/logic mix held steady at ~60%, consistent with sustained advanced node investment from TSMC, Samsung Foundry, and Intel Foundry.

Advanced Packaging

CY2025 systems revenue of $950M, up 70%+ YoY. Market share expanded from ~1% (2021) to "close to half" (2025). CY2026 guided at mid-to-high teens growth (down from prior "more than 20%" guide). Growth moderation attributed to customer facility constraints, not demand weakness. Management expects acceleration back above 20% in CY2027 as fab construction completes.

Service Business

$786M in Q2 — 16th consecutive year of annual growth, 12%+ CAGR. This is now a $3B+ annual run-rate business with high margins and extreme predictability. It provides a structural floor under KLA's revenue and earnings regardless of WFE cyclicality.

9. Quality of the Quarter

10. Balance Sheet Snapshot

The balance sheet is clean and optimized for shareholder returns. Gross debt of $6.1B is manageable against $6B+ LTM EBITDA and $1.26B quarterly FCF. KLA has a new $5B share repurchase authorization, and the TTM capital return of $3B represents ~3.5% of the pre-earnings market cap. Dividend yield of 0.56% adds to the total return. The capital allocation is effectively a structural buyback machine — reducing share count steadily while maintaining investment-grade credit quality.

11. Options & Volatility Diagnostics

Implied Volatility Event Profile

Positioning & Short Interest

The options market is distinctly bearish. The put/call OI ratio of 1.96 (nearly 2:1 puts to calls) is one of the highest readings in the WFE peer group and reflects active hedging or directional bets against the stock. IV at 59.5% is the highest in the period — higher than pre-earnings — signaling that the options market is pricing in continued uncertainty, likely around Investor Day (March 12) and Q3 earnings. Short interest at 2.2% is modest and not a crowded trade. The overall picture is that institutional investors are actively hedging KLAC exposure, likely on DRAM cost and H2 growth concerns.

Market Reaction vs. Benchmarks

Technical Levels

12. Stock Reaction Drivers

KLAC sold off 15.2% on D+1 — the most violent post-earnings reaction in the WFE group and the stock's largest single-day decline in over two years. The sell continued to -22.4% at the February 4 low before a partial recovery to -8.2% (Feb 25), then resumed selling to -20.2% by March 6.

Why a beat-and-raise quarter sold off 15%:

• DRAM cost headwind was entirely new information. No analyst had modeled 75-100 bps of margin pressure from KLA's own DRAM procurement costs. The surprise introduction of a cost headwind on a stock trading at 37x trailing P/E triggered immediate margin anxiety.
• Advanced packaging growth deceleration, however subtle, was a negative revision. Packaging was the highest-momentum growth vector in the KLA story. Guiding it down 300-500 bps — even if attributed to customer facility constraints — removed the "acceleration" element of the bull case.
• Rasgon's H2 math challenge went unanswered. The inability to quantitatively demonstrate share gain in aggregate revenue guidance created doubt about the outperformance narrative. If KLA is "just" growing in-line with WFE, the premium multiple is harder to justify.
• The quarter coincided with broader WFE/semi rotation. SOX fell 3.9% on D+1 as investors rotated out of equipment names on China concern and cycle-peak anxiety.

Was the selloff overdone? At $1,344 (32.4x forward P/E), the stock is approaching the low end of its historical valuation range for a growth WFE cycle. Consensus PT of $1,708 (27% upside) and continued estimate revisions upward suggest the Street views the selloff as excessive. However, the put/call ratio of 1.96 and IV at 59.5% indicate institutional concern has not abated. Investor Day on March 12 is the catalyst that could break the impasse.

13. What Mattered Less Than It Appeared

• WFE growth definition debate (KLA vs. Lam): Noise. Both companies converge to mid-$130B total when you include advanced packaging. The disagreement is about categorization, not demand.
• Tax rate step-up (14% → 14.5%): Immaterial impact on EPS. Pillar Two compliance is an industry-wide issue, not KLA-specific.
• China competition concerns: Wallace dismissed domestic Chinese process control competitors as materially behind. "Much more progress in process tools than in process control." No change in competitive positioning.
• OpEx growth (~$15M/quarter sequential): Well within KLA's 40-50% incremental operating margin model. Routine and expected.
• Tariff impact (50-100 bps): Already in models. Expected to diminish through CY2026. Not a new variable.

14. Post-Print Analyst Activity

15. Peer & Sector Read-Through

KLAC is the YTD laggard in WFE (+10.7% vs. AMAT +26.4%, ASML +20.8%, LRCX +16.4%), reflecting the post-earnings selloff penalty. On forward P/E, KLAC (32.4x) trades in-line with Lam (32.3x) but at a premium to Applied (27.1x) and a discount to ASML (37.2x). The premium to AMAT reflects KLA's higher margins and structural share gains in process control; the discount to ASML reflects ASML's monopoly positioning in EUV.

Read-Through: KLA's results confirm two sector-wide themes: (1) DRAM investment is accelerating faster than expected, with HBM driving process control intensity to logic-like levels — bullish for Lam (etch) and Applied (deposition/implant); (2) Advanced packaging remains a high-growth vector but is facility-constrained, suggesting the growth is being deferred rather than destroyed. The supply constraint language ("virtually sold out") is consistent with what other WFE companies have reported, confirming tight equipment supply industry-wide. KLAC's China affiliate rule commentary ($300-350M add-back) provides a positive read-through for AMAT and LRCX on China revenue normalization.

16. Investment Implications

Near-Term (Next 1-3 Months)

KLA Investor Day on March 12 is the critical near-term catalyst. If management presents an ambitious 2030 framework — expanded TAM estimates, process control intensity roadmap, advanced packaging targets, and sustainable margin guidance above 62% — the multiple can recover from the current depressed level. At $1,344 (32.4x forward), the stock has de-rated ~6 multiple points from its pre-earnings level. The RSI at 38.5 is approaching oversold, and the 100-day MA at $1,307 represents key support. Q3 earnings in April will confirm whether March is truly the GM trough.

Medium-Term (3-12 Months)

Three variables determine the medium-term trajectory: (1) Whether DRAM procurement costs normalize in H2 as management expects — this is the key margin variable; (2) Whether H2 revenue acceleration materializes — this is the growth variable; (3) Whether CY2027 order visibility continues building — this is the duration variable. If all three resolve positively, KLAC should re-rate toward the $1,700-$1,900 range (consensus PT). If DRAM costs persist and H2 disappoints, further de-rating toward AMAT's 27x forward multiple is possible, implying $1,100-$1,200.

Bull Case

• DRAM process control intensity inflection is structural and long-duration — TAM expands permanently as HBM/advanced DRAM approaches logic-like inspection requirements
• Advanced packaging share lock-in (1% → 50% in 4 years) creates a durable new revenue stream that compounds through CY2027+
• H2 acceleration materializes as customer facilities complete and deferred demand converts to revenue
• DRAM cost headwind normalizes in H2 as supply additions come online, restoring GM to 63%+
• Investor Day on March 12 resets the long-term framework with expanded TAM and margin targets
• Service business continues compounding at 12%+ CAGR, providing a rising floor
• Bull scenario FY2027: Revenue $17B+, GM 63%+, EPS $50+, stock at $1,800-$2,000 (36-40x)

Bear Case

• DRAM cost headwind persists beyond CY2026 as HBM keeps DRAM tight — structural margin cap at 61%
• H2 acceleration is the familiar WFE "second half hockey stick" that doesn't fully materialize
• Rasgon's math is correct — share gains are not visible in aggregate revenue, and KLA is merely growing with WFE
• Advanced packaging growth continues moderating as customer facility constraints extend into CY2027
• China export controls tighten further, reducing the mid-to-high-20s% China revenue contribution
• WFE cycle peaks in CY2026 as AI capex decelerates, compressing equipment multiples industry-wide
• Bear scenario FY2027: Revenue $14.5B, GM 60%, EPS $38-40, stock at $1,000-$1,200 (26-30x)

Conviction Assessment

The Q2 print itself was solid — the selloff is about narrative, not execution. Three legitimate forward concerns emerged (DRAM costs, packaging deceleration, H2 math), but none are existential and all have plausible positive resolutions. The structural bull case — DRAM intensity inflection, packaging share lock-in, service compounding — remains intact. The question is timing: if DRAM costs normalize and H2 accelerates, the stock is trading at a cyclical discount on structural improvements. If they don't, the premium erodes. At 32.4x forward with 27% upside to consensus PT, the risk/reward is moderately asymmetric to the upside, but the near-term catalyst is Investor Day — the thesis stands or falls on whether management can reset the narrative on March 12.

17. What to Watch Next

18. Appendix

Senior Executives

Research Analysts on Q2 FY2026 Call

19. Sources

Sources: Bloomberg (financial data, consensus estimates, analyst recommendations, price history, options data, peer comparisons), KLA Corporation Q2 FY2026 earnings call transcript (January 29, 2026), KLA Corporation Q1 FY2026 earnings call transcript (October 29, 2025)